The Unholy Grail of cancer screening: or is it just about the Benjamins?

Artikel in diesem Heft

1. Frontmatter
2. Editorial
3. Macroprolactinaemia – some progress but still an ongoing problem
4. Review
5. Understanding the circulating forms of cardiac troponin: insights for clinical practice
6. Opinion Papers
7. New insights in preanalytical quality
8. IFCC recommendations for internal quality control practice: a missed opportunity
9. Genetics and Molecular Diagnostics
10. Evaluation of error detection and treatment recommendations in nucleic acid test reports using ChatGPT models
11. General Clinical Chemistry and Laboratory Medicine
12. Pre-analytical phase errors constitute the vast majority of errors in clinical laboratory testing
13. Improving the efficiency of quality control in clinical laboratory with an integrated PBRTQC system based on patient risk
14. IgA-type macroprolactin among 130 patients with macroprolactinemia
15. Prevalence and re-evaluation of macroprolactinemia in hyperprolactinemic patients: a retrospective study in the Turkish population
16. Defining dried blood spot diameter: implications for measurement and specimen rejection rates
17. Screening primary aldosteronism by plasma aldosterone-to-angiotensin II ratio
18. Assessment of serum free light chain measurements in a large Chinese chronic kidney disease cohort: a multicenter real-world study
19. Beyond the Hydrashift assay: the utility of isoelectric focusing for therapeutic antibody and paraprotein detection
20. Direct screening and quantification of monoclonal immunoglobulins in serum using MALDI-TOF mass spectrometry without antibody enrichment
21. Effect of long-term frozen storage on stability of kappa free light chain index
22. Impact of renal function impairment on kappa free light chain index
23. Standardization challenges in antipsychotic drug monitoring: insights from a national survey in Chinese TDM practices
24. Potential coeliac disease in children: a single-center experience
25. Vitamin D metabolome in preterm infants: insights into postnatal metabolism
26. Candidate Reference Measurement Procedures and Materials
27. Development of commutable candidate certified reference materials from protein solutions: concept and application to human insulin
28. Reference Values and Biological Variations
29. Biological variation of serum cholinesterase activity in healthy subjects
30. Hematology and Coagulation
31. Diagnostic performance of morphological analysis and red blood cell parameter-based algorithms in the routine laboratory screening of heterozygous haemoglobinopathies
32. Cancer Diagnostics
33. Promising protein biomarkers for early gastric cancer: clinical performance of combined detection
34. Infectious Diseases
35. The accuracy of presepsin in diagnosing neonatal late-onset sepsis in critically ill neonates: a prospective study
36. Corrigendum
37. The Unholy Grail of cancer screening: or is it just about the Benjamins?
38. Letters to the Editor
39. Analytical validation of hemolysis detection on GEM Premier 7000
40. Reconciling reference ranges and clinical decision limits: the case of thyroid stimulating hormone
41. Contradictory definitions give rise to demands for a right to unambiguous definitions
42. Biomarkers to measure the need and the effectiveness of therapeutic supplementation: a critical issue